Shanghai Fosun Pharmaceutical (Group) Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Fosun Pharmaceutical (Group) has a total shareholder equity of CN¥58.9B and total debt of CN¥32.4B, which brings its debt-to-equity ratio to 55%. Its total assets and total liabilities are CN¥115.5B and CN¥56.7B respectively. Shanghai Fosun Pharmaceutical (Group)'s EBIT is CN¥1.4B making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥16.1B.
Key information
55.0%
Debt to equity ratio
CN¥32.40b
Debt
| Interest coverage ratio | -0.7x |
| Cash | CN¥16.10b |
| Equity | CN¥58.86b |
| Total liabilities | CN¥56.68b |
| Total assets | CN¥115.54b |
Recent financial health updates
Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden
Jul 28
Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?
Mar 18Recent updates
Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year
Aug 03Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden
Jul 28Market Still Lacking Some Conviction On Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196)
May 23Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next
May 01We Think You Can Look Beyond Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Lackluster Earnings
Apr 02Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?
Mar 18Are Investors Undervaluing Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) By 48%?
Feb 26Financial Position Analysis
Short Term Liabilities: 600196's short term assets (CN¥34.8B) do not cover its short term liabilities (CN¥37.4B).
Long Term Liabilities: 600196's short term assets (CN¥34.8B) exceed its long term liabilities (CN¥19.3B).
Debt to Equity History and Analysis
Debt Level: 600196's net debt to equity ratio (27.7%) is considered satisfactory.
Reducing Debt: 600196's debt to equity ratio has reduced from 68.9% to 55% over the past 5 years.
Debt Coverage: 600196's debt is not well covered by operating cash flow (10.8%).
Interest Coverage: 600196 earns more interest than it pays, so coverage of interest payments is not a concern.